We are live on ! Find out more
AHL

Abel Hall LLC Portfolio holdings

AUM $579M
1-Year Est. Return 54.21%
This Fund
S&P 500
This Quarter Est. Return
+9.62%
1 Year Est. Return
+54.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$216M
AUM Growth
+$50.6M
Cap. Flow
+$34.5M
Cap. Flow %
15.95%
Top 10 Hldgs %
43.1%
Holding
328
New
126
Increased
90
Reduced
60
Closed
39

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.88%
2 Technology 11.01%
3 Financials 6.83%
4 Energy 5.7%
5 Consumer Discretionary 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCGN icon
276
Ocugen
OCGN
$346M
$14.5K 0.01%
14,918
+3,197
+27% +$2.65K
ZURA icon
277
Zura Bio
ZURA
$499M
$14K 0.01%
+13,343
New +$15.9K
URG
278
Ur-Energy
URG
$513M
$13.6K 0.01%
12,981
+2,679
+26% +$2.14K
LAB icon
279
Standard BioTools
LAB
$271M
$13.4K 0.01%
+11,185
New +$12.4K
ESPR
280
DELISTED
Esperion Therapeutics
ESPR
$12.1K 0.01%
+12,312
New +$12.3K
ELEV
281
DELISTED
Elevation Oncology
ELEV
$12K 0.01%
+32,799
New +$10.9K
OVID icon
282
Ovid Therapeutics
OVID
$525M
$10.7K ﹤0.01%
32,348
+22,110
+216% +$6.66K
IPSC icon
283
Century Therapeutics
IPSC
$351M
$9.82K ﹤0.01%
+17,582
New +$9.43K
LESL icon
284
Leslie's
LESL
$4.7M
$7.76K ﹤0.01%
+924
New +$12.2K
IVVD icon
285
Invivyd
IVVD
$232M
$7.58K ﹤0.01%
10,604
+530
+5% +$376
GBIO
286
DELISTED
Generation Bio
GBIO
$7.54K ﹤0.01%
+2,357
New +$9.08K
ALXO icon
287
ALX Oncology
ALXO
$268M
$6.31K ﹤0.01%
+15,209
New +$7.68K
OPEN icon
288
Opendoor
OPEN
$2.71B
$6.12K ﹤0.01%
11,868
-495
-4% -$358
SCWO icon
289
374Water
SCWO
$57.4M
$4.08K ﹤0.01%
+1,259
New +$4.23K
ADC icon
290
Agree Realty
ADC
$8.86B
-5,124
Closed -$396K
AIT icon
291
Applied Industrial Technologies
AIT
$11.9B
-911
Closed -$205K
AJG icon
292
Arthur J. Gallagher & Co
AJG
$61.6B
-651
Closed -$225K
AMGN icon
293
Amgen
AMGN
$204B
-744
Closed -$232K
BBJP icon
294
JPMorgan BetaBuilders Japan ETF
BBJP
$19.9B
-3,769
Closed -$212K
BORR
295
Borr Drilling
BORR
$1.32B
-13,274
Closed -$29.1K
CHPT icon
296
ChargePoint
CHPT
$243M
-520
Closed -$6.3K
CHRS icon
297
Coherus Oncology
CHRS
$205M
-12,249
Closed -$9.88K
CORT icon
298
Corcept Therapeutics
CORT
$12.2B
-2,082
Closed -$238K
ENB icon
299
Enbridge
ENB
$104B
-6,009
Closed -$266K
EPR icon
300
EPR Properties
EPR
$4.53B
-5,600
Closed -$295K

Similar funds

Abel Hall LLC's Q2 2025 Portfolio in Review

As of Q2 2025, Abel Hall LLC held 328 positions worth $216M, up 31% from $166M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Abel Hall LLC deployed $34.5M of net new capital in Q2 2025, opening 126 new positions and adding to 90 existing holdings. Its largest new stake was Whirlpool: 11,882 shares worth $1.21M.

By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 60% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Dimensional International Core Equity 2 ETF, an estimated $502K trimmed.

  • Abel Hall LLC's largest Q2 2025 buy was Whirlpool: 11,882 shares worth $1.21M.
  • Abel Hall LLC added most to Microsoft in Q2 2025, an estimated $1.09M increase.
  • Abel Hall LLC's biggest Q2 2025 reduction was Dimensional International Core Equity 2 ETF, cutting an estimated $502K.
  • Abel Hall LLC fully exited VICI Properties in Q2 2025, selling an estimated $723K.
  • Abel Hall LLC's ten largest holdings make up 43% of its $216M portfolio in Q2 2025.
  • Abel Hall LLC opened 126 new positions and closed 39 in Q2 2025.
  • Abel Hall LLC's portfolio value rose 31% quarter-over-quarter to $216M.

Based on Abel Hall LLC's 13F filing for Q2 2025, filed 23 Jul 2025.